Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

GlaxoSmithKline PLC (NYSE:GSK)

40.85
Delayed Data
As of Jul 26
 -1.11 / -2.65%
Today’s Change
37.20
Today|||52-Week Range
45.58
+6.08%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Revenue and IncomeNet Revenues41.5B37.9B36.5B37.5B
 
 
 
 
 
Cost of Goods Sold10.6B9.4B11.1B10.3B
 
 
 
 
 
Depreciation And Amortization2.2B2.4B2.5B2.4B
 
 
 
 
 
 
Operating ExpensesGross Income28.7B26.0B22.9B24.8B
 
 
 
 
 
General Expenses17.5B16.9B16.2B15.7B
 
 
 
 
 
Research And Development5.4B5.2B5.2B4.7B
 
 
 
 
 
Total Operating Expenses30.3B28.8B29.8B28.4B
 
 
 
 
 
 
Non-Operating ExpensesOperating Income11.2B9.1B6.7B9.1B
 
 
 
 
 
Extraordinary Credit78.3M19.8M47.3M191.1M
 
 
 
 
 
Extraordinary Charge-3.2B-4.5B-7.2B-7.1B
 
 
 
 
 
Interest Expense On Debt1.1B1.1B1.0B923.2M
 
 
 
 
 
Equity In Earnings67.3M49.4M21.4M6.7M
 
 
 
 
 
Other Expenses3.3B1.2B17.4B1.3B
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income10.3B4.8B16.0B2.6B
 
 
 
 
 
Income Taxes-1.6B-225.6M-3.3B-1.2B
 
 
 
 
 
Minority Interest-300.7M-123.5M-76.3M-201.9M
 
 
 
 
 
Net Income8.5B4.5B12.8B1.2B
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS2.4B2.4B2.4B2.4B
 
 
 
 
 
Shares To Calculate EPS Diluted2.5B2.4B2.4B2.5B
 
 
 
 
 
 
Earnings Per ShareEPS$3.52$1.89$5.32$0.51
 
 
 
 
 
EPS Diluted$3.46$1.86$5.26$0.50